Local Versus Systemic Immunoreactivity to Collagen and the Collage-Like Region of Clq in Rheumatoid Arthritis and SLE

References

• Seki N, Sudo Y, Yoshioka T, Sugihara S, Futjitsu T, Sakuma S, et al. 5pe II collagen-induced arthritis I. Induction and perpetuation of arthritis reguire synergy between humoral and cell-mediated immunity. J Immunol 1988; 140(5)1477–84
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II-induced arthritis in mice. Scand J Immunol 1985; 22: 295–306
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti type II collagen antibodies. Arthritis Rheum 1986; 29(3)400–10
   PubMedGoogle Scholar
• Terato K, Hasty K A, Reife R A, Cremer M A, Kang A H, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Irnmunol 1992; 148(7)2103–8
   PubMed Web of Science ®Google Scholar
• Heinz H-P, Brackertz D, Loos M. Enzymatic alteration of Clq, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen. FEBS Lett 1988; 228(2)332–6
   PubMed Web of Science ®Google Scholar
• Heinz H-P, Rubin K, Laurell A-B, Loos M. Common epitopes in Clq and collagen type II. Mol Immunol 1989; 26(2)163–9
   PubMed Web of Science ®Google Scholar
• Heinz H-P, Burger R, Golan M D, Loos M. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of Clq. J Immunol 1984; 132(2)804–8
   PubMed Web of Science ®Google Scholar
• Siegert C EH, Daha M R, Lobatto S, van der Voort E AM, Breedveld FC. IgG autoantibodies to Clq do not detectable influence complement activation in vivo and in vitro in SLE. Immunol Res 1992; 11(2)91–7
   PubMed Web of Science ®Google Scholar
• Czerkinsky C C, Nilsson L-A, Nygren H, Ouchterlony O, Tarkowski A. A Solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Irnmunol Methods 1983; 65: 109–21
   PubMed Web of Science ®Google Scholar
• Sedgwick J D, Holt PG. A solid-phase immunoenzy-matic technique for the enumeration of specific antibody-secreting cells. J Irnmunol Methods 1983; 57: 301–9
   PubMed Web of Science ®Google Scholar
• Andriopoulos N A, Mesecky J, Miller E J, Bradly EL. Antibodies to native and denatured collagens in sera of patients with rheumatoid artritis. Arthritis Rheum 1976; 19(3)613–7
   PubMedGoogle Scholar
• Rowley M J, Mackay I R, Brand C A, Bateman J F, Chan D. Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 1992; 1265–9
   Web of Science ®Google Scholar
• Dyer P A, Clague R B, Klouda P T, Firth S, Harris R, Holt P LT. HLA antigens in patients with rheumatoid arthritis and antibodies to native type II collagen. Tissue Antigens 1982; 20: 394
   PubMedGoogle Scholar
• Collier D H, Kerwar S S, Garovoy M R, Fye K H, Stobo JD. Anticollagen antibodies and immune response gene products in rheumatoid arthritis. Arthritis Rheum 1984; 27: 1201
   PubMedGoogle Scholar
• Wooley P H, Luthra H S, O'Duffy J D, Bunch T W, Moore S B, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens 1984; 23: 263
   PubMedGoogle Scholar
• Klimiuk P S, Clague R B, Grennan D M, Dyer P A, Smeaton I, Harris R. Autoimmunity to native type II collagen — a distinct genetic subset of rheumatoid arthritis. J Rheumatol 1985; 12: 365
   PubMedGoogle Scholar
• Rowley M, Tait B, Mackay I R, Cunningham T, Phillips B. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum 1986; 29(2)174–84
   PubMedGoogle Scholar
• Banerjee S, Luthra H S, Moore S B, O'Fallon WM. Serum IgG antinative type II collagen antibodies in rheumatoid arthritis: association with DR4 and lack of clinical correlation. Clin Exp Rheumatol 1988; 6: 373–80
   PubMed Web of Science ®Google Scholar
• Morgan K, Clague R B, Collins I, Ayad S, Phinn S D, Holt P JL. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32(2)139–45
   PubMed Web of Science ®Google Scholar
• Ferriss J, Cooper S, Roessner K, Hochberg M. Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol 1990; 17(7)880–4
   PubMed Web of Science ®Google Scholar
• Steffen C, Ludvig H, Knapp W. Collagen-anti collagen immune complexes in rheumatoid arthritis synovial fluid. Z Immun Forsch 1974; 147: 220
   Google Scholar
• Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985; 28(3)241–8
   PubMedGoogle Scholar
• Anderson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990; 20: 1061–6
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Klareskog L, Anderson M, Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986; 24: 84–9
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koop-Man W. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32(9)1087–92
   PubMed Web of Science ®Google Scholar
• Rönnelid J, Lysholm J, Engström-Laurent A, Klareskog L, Heyman B. Local collagen type II reactive antibody production in rheumatoid arthritis synovial fluid: evidence for a HLA-DR4 restricted IgG response. Arthritis Rheum, in press
   Google Scholar
• Uwatoko S, Aotsuka S, Okawa M, et al. Characterization of Clq-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 30: 104–16
   PubMedGoogle Scholar
• Uwatoko S, Aotsuka S, Okawa M, et al. Clq solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of Clq in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 69: 98–106
   PubMed Web of Science ®Google Scholar
• Antes U, Heinz H-P, Loos M. Evidence for the presence of autoantibodies to the collagen-like portion of Clq in systemic lupus erythematosus. Arthritis Rheum 1988; 31(4)457–64
   PubMedGoogle Scholar
• Siegert C EH, Daha M, Westedt M-L, van het Voort E, Breedveld F. IgA autoantibodies against Clq are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991; 18: 230–4
   PubMed Web of Science ®Google Scholar
• Rönnelid J, Huang Y H, Norrlander T, Rogberg S, Nilsson B, Gustafsson R, et al. Short Time Kinetics of the Humoral Anti Clq Response in SLE Using the ELISPOT Method: Fast Decline in Production in Response to Steroids. Scand J Immunol 1994; 40: 243–50
   PubMed Web of Science ®Google Scholar
• Siegert C EH, Daha M R, van der Voort E AM, Breedveld FC. IgG and IgA antibodies to the collagen-like region of Clq in rheumatoid vasculitis. Arthritis Rheum 1990; 33(11)164634
   Google Scholar
• Moreland L W, Gay R E, Gay S. Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60: 412–8
   PubMedGoogle Scholar